Acuitive Technologies, Inc.
Acuitive Technologies is a medical device manufacturer founded in 2014, committed to advancing orthopedic surgery through innovative material science technologies and device designs. Their core biomaterial, CITREGEN, is designed to replicate the cellular support network of bone and promote tissue regeneration. The company develops and markets a range of orthopedic products, including tendon fixation devices, bone void fillers, and ligament anchors, utilizing their proprietary citrate-based biomaterials. They collaborate with research institutes and have received FDA clearances for several products, emphasizing their focus on regenerative engineering and biocompatible biomaterials.
Industries
Nr. of Employees
small (1-50)
Acuitive Technologies, Inc.
Patents
Products
Resorbable tendon/ligament fixation interference screw
Implantable interference screw intended for soft tissue reattachment in shoulder, elbow, foot/ankle, knee, and hand/wrist surgeries; engineered for tendon-friendly geometry and tap-in insertion.
Knotless suture anchor (resorbable)
Knotless suture anchor designed to secure sutures into bone for soft tissue reattachment, enabling use of surgeon-preferred sutures and tap-in implantation.
Synthetic bioactive bone graft / bone void filler
Pliable, sponge-like synthetic bone graft material intended to fill bony voids in extremities and pelvis; designed to resorb predictably and be replaced by host bone, and to be combined with saline, blood, or bone marrow as needed.
Porous interpositional scaffolds (rotator cuff / tendon-bone interface)
Porous interpositional scaffold concepts designed to be deployed at tendon–bone interfaces to support tendon–bone integration and regeneration.
Osteotomy wedges and structural fusion implants
Implant concepts intended to support fusion and osteotomy procedures by enhancing mechanical stability and optimizing correction and fusion parameters.
Spinal interbody spacer concepts
Interbody spacer designs intended to support spinal fusion by enhancing sagittal alignment and mechanical stability.
Resorbable tendon/ligament fixation interference screw
Implantable interference screw intended for soft tissue reattachment in shoulder, elbow, foot/ankle, knee, and hand/wrist surgeries; engineered for tendon-friendly geometry and tap-in insertion.
Knotless suture anchor (resorbable)
Knotless suture anchor designed to secure sutures into bone for soft tissue reattachment, enabling use of surgeon-preferred sutures and tap-in implantation.
Synthetic bioactive bone graft / bone void filler
Pliable, sponge-like synthetic bone graft material intended to fill bony voids in extremities and pelvis; designed to resorb predictably and be replaced by host bone, and to be combined with saline, blood, or bone marrow as needed.
Porous interpositional scaffolds (rotator cuff / tendon-bone interface)
Porous interpositional scaffold concepts designed to be deployed at tendon–bone interfaces to support tendon–bone integration and regeneration.
Osteotomy wedges and structural fusion implants
Implant concepts intended to support fusion and osteotomy procedures by enhancing mechanical stability and optimizing correction and fusion parameters.
Spinal interbody spacer concepts
Interbody spacer designs intended to support spinal fusion by enhancing sagittal alignment and mechanical stability.
Services
Joint R&D programs with academic and research institutes to develop and evaluate citrate-based biomaterials and device designs.
Execution or coordination of preclinical in vivo studies and biomechanical/biochemical evaluations to support product development and regulatory filings.
Establishment of distribution agreements and partnerships to commercialize orthopedic implant products through partner networks.
Joint R&D programs with academic and research institutes to develop and evaluate citrate-based biomaterials and device designs.
Execution or coordination of preclinical in vivo studies and biomechanical/biochemical evaluations to support product development and regulatory filings.
Establishment of distribution agreements and partnerships to commercialize orthopedic implant products through partner networks.
Expertise Areas
- Biomaterials development (citrate-based composites)
- Orthopedic implant design
- Resorbable polymer engineering
- Porous scaffold and bone graft development
Key Technologies
- Citrate-based polymer–bioceramic composites
- Porous scaffold fabrication
- Resorbable/bioactive polymer engineering
- Wound-management hydrogels
News & Updates
Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer to drive new product development in musculoskeletal tissue regeneration.
Acuitive Technologies received FDA 510(k) clearance for CITRELOCK® DUO, a new sports medicine fixation device for biceps tenodesis and tendon transfer procedures.
Acuitive Technologies received FDA 510(k) clearance for CITREGRAFT™, a synthetic bioactive bone void filler that is resorbed and replaced by natural bone.
Robin Gehrmann, M.D., successfully implanted the first CITRELOCK® ACL Tendon Fixation Device, showcasing its application in ACL reconstruction.
Northwestern biomedical engineer Guillermo A. Ameer developed CITREGEN®, a biomaterial technology now used in Stryker’s CITRELOCK® device, making it widely available for musculoskeletal surgeries.
Acuitive received FDA clearance for CITRESPLINE and CITRELOCK® Ligament Reconstruction Devices, utilizing their CITREGEN biomaterial technology.
Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer to drive new product development in musculoskeletal tissue regeneration.
Acuitive Technologies received FDA 510(k) clearance for CITRELOCK® DUO, a new sports medicine fixation device for biceps tenodesis and tendon transfer procedures.
Acuitive Technologies received FDA 510(k) clearance for CITREGRAFT™, a synthetic bioactive bone void filler that is resorbed and replaced by natural bone.
Robin Gehrmann, M.D., successfully implanted the first CITRELOCK® ACL Tendon Fixation Device, showcasing its application in ACL reconstruction.
Northwestern biomedical engineer Guillermo A. Ameer developed CITREGEN®, a biomaterial technology now used in Stryker’s CITRELOCK® device, making it widely available for musculoskeletal surgeries.
Acuitive received FDA clearance for CITRESPLINE and CITRELOCK® Ligament Reconstruction Devices, utilizing their CITREGEN biomaterial technology.